Amit Mahipal
Impact in
- Oncology top 1%
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 102
- Pancreatic and Hepatic Oncology Research 49
- Cancer Immunotherapy and Biomarkers 14
-
- Cancer Genomics and Diagnostics 22
- Co-authors
- Sri Harsha Tella (30 shared papers)Anuhya Kommalapati (22 shared papers)Richard D. Kim (19 shared papers)Sakti Chakrabarti (36 shared papers)Mokenge Peter Malafa (5 shared papers)Mitesh J. Borad (26 shared papers)Shilpa Gupta (5 shared papers)Robert R. McWilliams (22 shared papers)
- Journals
- Cancers (19 papers)Annals of Oncology (16 papers)The Oncologist (11 papers)JCO Precision Oncology (11 papers)Journal of Clinical Oncology (7 papers)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Amit Mahipal
209 papers receiving 7.1k citations
Amit Mahipal's Hit Papers
Peers
Comparison fields: 5 of 114
- Oncology 3.1k
- Hepatology 729
- Cancer Research 830
- Otorhinolaryngology 208
- Surgery 1.8k
Countries citing papers authored by Amit Mahipal
This map shows the geographic impact of Amit Mahipal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amit Mahipal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amit Mahipal more than expected).
Fields of papers citing papers by Amit Mahipal
This network shows the impact of papers produced by Amit Mahipal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amit Mahipal. The network helps show where Amit Mahipal may publish in the future.
Co-authors
The 25 scholars most cited alongside Amit Mahipal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 219 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort Hit paper breakdown → | 2016 | 715 |
| 2 | Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study Hit paper breakdown → | 2020 | 469 |
| 3 | Futibatinib for FGFR2 -Rearranged Intrahepatic Cholangiocarcinoma Hit paper breakdown → | 2023 | 396 |
| 4 | A Phase 2 Multi-institutional Study of Nivolumab for Patients With Advanced Refractory Biliary Tract Cancer Hit paper breakdown → | 2020 | 351 |
| 5 | 2019 | 330 | |
| 6 | Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma Hit paper breakdown → | 2024 | 229 |
| 7 | 2016 | 216 | |
| 8 | 2022 | 179 | |
| 9 | 2017 | 166 | |
| 10 | 2020 | 163 | |
| 11 | 2015 | 137 | |
| 12 | 2016 | 135 | |
| 13 | 2021 | 126 | |
| 14 | 2014 | 118 | |
| 15 | A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim results Hit paper breakdown → | 2024 | 104 |
| 16 | 2017 | 103 | |
| 17 | 2020 | 98 | |
| 18 | 2019 | 83 | |
| 19 | 2020 | 78 | |
| 20 | 2018 | 77 |
About Amit Mahipal
Amit Mahipal is a scholar working on Oncology, Cancer Research, Hepatology, Surgery and Pathology and Forensic Medicine, having authored 219 papers that have together received 7.2k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (50 papers), Pancreatic and Hepatic Oncology Research (49 papers), Hepatocellular Carcinoma Treatment and Prognosis (24 papers), Cancer Genomics and Diagnostics (22 papers), Fibroblast Growth Factor Research (19 papers), Cancer Immunotherapy and Biomarkers (14 papers), Neuroendocrine Tumor Research Advances (12 papers) and Genetic factors in colorectal cancer (12 papers). The work is most often cited by research in Oncology (3.1k citations), Hepatology (729 citations), Cancer Research (830 citations), Otorhinolaryngology (208 citations) and Surgery (1.8k citations). Amit Mahipal has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Sri Harsha Tella, Anuhya Kommalapati, Richard D. Kim, Sakti Chakrabarti, Mokenge Peter Malafa, Mitesh J. Borad, Shilpa Gupta, Robert R. McWilliams, Zhaohui Jin and Rory L. Smoot. Their work appears in journals such as Cancers, Annals of Oncology, The Oncologist, JCO Precision Oncology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.